You have 9 free searches left this month | to do more

siremadlin

Siremadlin is a drug used to treat Acute Myeloid Leukemia and Myelofibrosis. Siremadlin is being actively studied in 2 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsNovartis Investigative Site
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.
Not yet recruiting
  • Acute Myeloid Leukemia
  • siremadlin
  • +2 more
  • (no location specified)
2022-03-29
Mar 29, 2022
N
Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
Recruiting
  • Myelofibrosis
  • Adelaide, South Australia, Australia
  • +33 more
2022-01-31
Jan 31, 2022